Prothena Corp Public (PRTA) Return on Sales Growth (3y) (2015 - 2026)

Prothena Corp Public (PRTA) Return on Sales Growth (3y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 0.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Prothena Corp Public 458.13 Mn 128.67 Mn - 22.00

Historic Data

Download Data
DateValue
Mar 31, 2026 22.00
Dec 31, 2025 -1,026.00
Sep 30, 2025 15.00
Jun 30, 2025 3.00
Mar 31, 2025 10.00
Dec 31, 2024 1.00
Sep 30, 2024 -62.00
Jun 30, 2024 0.00
Mar 31, 2024 -1,215.00
Dec 31, 2023 -128.00
Sep 30, 2023 195.00
Jun 30, 2023 121.00
Mar 31, 2023 146.00
Dec 31, 2022 84.00
Sep 30, 2022 65.00
Jun 30, 2022 63.00
Mar 31, 2022 81.00
Dec 31, 2021 88.00
Sep 30, 2021 97.00
Jun 30, 2021 215.00